TY  - BOOK
AU  - Marilyn K. Glassberg
TI  - Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
KW  - Computer science, information & general works
UR  - https://new.zodml.org/sites/default/files/2023-07/cardiovascular_risks_bleeding_risks_and_clinical_events_from_3_phase_iii_trials_of_pirfenidone_in_patients_with_idiopathic_pulmonary_fibrosis.pdf
ER  -